Atopic dermatitis (eczema): open trials in Mexico

4 open trials have a site in Mexico. Registry data; only the trial team decides who can take part.

NCT05735483
A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
Trial Treatment · Phase 3 · Eli Lilly and Company
Scientia Investigacion Clinica S.C., Chihuahua City · PanAmerican Clinical Research - Cuernavaca, Cuernavaca · Hospital Infantil de Mexico Federico Gomez, Mexico City · Trials in Medicine, Mexico City · Hospital de Jesús Nazareno, Mexico City · Eukarya PharmaSite, Monterrey · Hospital Universitario Dr. Jose Eleuterio González, Monterrey · Arké SMO S.A de C.V, Veracruz · Instituto Dermatologico de Jalisco, Zapopan
Registry updated 2026-10-26
NCT06807281
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Trial Treatment · Phase 3 · Pfizer
Servicios Hospitalarios de Mexico S.A. DE C.V., Chihuahua City · Hospital Infantil de Mexico Federico Gomez, Mexico City · Eukarya Pharmasite S.C., Monterrey · Arké SMO S.A de C.V, Veracruz
Registry updated 2026-10-13
NCT06807268
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Trial Treatment · Phase 3 · Pfizer
Servicios Hospitalarios de México S.A. de C.V. (Hospital Angeles Chihuahua), Chihuahua City · Hospital Infantil de Mexico Federico Gomez, Mexico City · Eukarya Pharmasite S.C., Monterrey · Arké SMO S.A de C.V, Veracruz
Registry updated 2026-09-25
NCT07259343
Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population
Trial Treatment · Universidad Autónoma de Aguascalientes
Universidad Autónoma de Aguascalientes, Aguascalientes
Registry updated 2025-12-02

All Atopic dermatitis (eczema) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error

Atopic dermatitis (eczema): open trials in Mexico

A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population